NASH, NAFLD, what's that?

被引：0
|
作者：
Lecerf, Jean-Michel [1 ]
机构：
[1] Inst Pasteur, Ctr Prevent Sante Longevite, Serv Nutr & Act Phys, Lille, France
来源：
CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION | 2022年 / 26卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：80 / 80
页数：1
相关论文
共 50 条
  • [21] A pivotal year for NAFLD and NASH therapeutics
    Dufour, Jean-Francois
    NATURE REVIEWS ENDOCRINOLOGY, 2024, 20 (02) : 75 - 76
  • [22] PREVENTION AND PHARMACOLOGICAL INTERVENTIONS IN NAFLD/NASH
    De Block, C.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A13 - A13
  • [23] The role of IFN in the development of NAFLD and NASH
    Mohlenberg, Michelle
    Terczynska-Dyla, Ewa
    Thomsen, Karen Louise
    George, Jacob
    Eslam, Mohammed
    Gronbaek, Henning
    Hartmann, Rune
    CYTOKINE, 2019, 124
  • [24] Current medical treatment for NAFLD/NASH
    Masrour, Oumnia
    Bardou-Jacquet, Edouard
    NUTRITION CLINIQUE ET METABOLISME, 2023, 37 (02): : 72 - 76
  • [25] Innate Immunity and Inflammation in NAFLD/NASH
    Arrese, Marco
    Cabrera, Daniel
    Kalergis, Alexis M.
    Feldstein, Ariel E.
    DIGESTIVE DISEASES AND SCIENCES, 2016, 61 (05) : 1294 - 1303
  • [26] A pivotal year for NAFLD and NASH therapeutics
    Jean-François Dufour
    Nature Reviews Endocrinology, 2024, 20 : 75 - 76
  • [27] Predicting NASH in NAFLD without a Biopsy
    Klein, Friederike
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2021, 59 (07):
  • [28] Predicting the future burden of NAFLD and NASH
    Mahady, Suzanne E.
    George, Jacob
    JOURNAL OF HEPATOLOGY, 2018, 69 (04) : 774 - 775
  • [29] Imaging biomarkers of NAFLD, NASH, and fibrosis
    Ajmera, Veeral
    Loomba, Rohit
    MOLECULAR METABOLISM, 2020, 50
  • [30] Evolving Role for Pharmacotherapy in NAFLD/NASH
    Attia, Suzanna L.
    Softic, Samir
    Mouzaki, Marialena
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2021, 14 (01): : 11 - 19
12345